Advertisement

BMC Pharmacology

, 9:S24 | Cite as

Phosphodiesterase-5 inhibition and cardioprotection: potential role of hydrogen sulfide

  • Rakesh C Kukreja
  • Vinh Q Chau
  • Nicholas N Hoke
  • Antonio Abbate
  • Amit Varma
  • Ramzi A Ockaili
  • Stefano Toldo
  • Fadi N Salloum
Open Access
Oral presentation
  • 1k Downloads

Keywords

Infarct Size Hydrogen Sulfide Tadalafil Vardenafil Coronary Artery Ligation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Background

Our laboratory has shown that phosphodiesterase-5 (PDE-5) inhibitors including sildenafil, vardenafil and tadalafil induce powerful protection against myocardial ischemia-reperfusion injury. We have shown that sildenafil protects through activation PKC, expression of eNOS/iNOS, protein kinase G (PKG) and opening of mitochondrial KATP (mitoKATP) channels [1]. Hydrogen sulfide (H2S) is a gaseous molecule that is produced enzymatically and exerts physiological actions in the cardiovascular system. Similar to PKG, H2S has been shown to protect the heart via opening of mitoKATP channel [2]. In the current study, we hypothesized that tadalafil, the long acting inhibitor of PDE-5 mediates cardioprotection through H2S signaling in a PKG-dependent fashion.

Methods and results

After baseline transthoracic echocardiography (TTE), adult ICR mice were injected i.p. with vehicle (10% DMSO) or tadalafil (1 mg/kg) with or without KT5823 (KT, PKG blocker, 1 mg/kg) or dl-propargylglycine [PAG, Cystathionine-γ-lyase (CSE, H2S-producing enzyme) blocker; 50 mg/kg] 1 h prior to coronary artery ligation for 30 min and reperfusion for 24 h, whereas C57BL-wild type and CSE-knockout mice were treated with either vehicle or tadalafil. After reperfusion, TTE was performed and hearts were collected for infarct size (IS) measurement using TTC staining. Survival was increased with tadalafil (95%) compared with control (65%, P < 0.05). Infarct size was reduced with tadalafil (13.2 ± 1.7%) compared to vehicle (40.6 ± 2.5%; P < 0.05). KT and PAG abolished tadalafil-induced protection (IS: 39.2 ± 1% and 51.2 ± 2.4%, respectively) similar to genetic deletion of CSE (47.2 ± 5.1%). Moreover, tadalafil preserved fractional shortening (FS: 31 ± 1.5%) compared to control (FS: 22 ± 4.8%, P < 0.05). Baseline FS was 44 ± 1.7%. KT and PAG abrogated the preservation of LV function with tadalafil by decline in FS to 17 ± 1% and 23 ± 3%, respectively. Compared to vehicle, myocardial H2S production was significantly increased with tadalafil and was abolished with KT.

Conclusion

PKG activation with tadalafil limits myocardial infarction and preserves LV function through H2S signaling.

References

  1. 1.
    Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, Fisher PW, Wittkamp M, Hawkins J, Chou E, Kukreja AK, Wang X, Marwaha VR, Xi L: Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Vascul Pharmacol. 2005, 42: 219-32. 10.1016/j.vph.2005.02.010.CrossRefPubMedGoogle Scholar
  2. 2.
    Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA. 2007, 104: 15560-5. 10.1073/pnas.0705891104.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Kukreja et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • Rakesh C Kukreja
    • 1
  • Vinh Q Chau
    • 1
  • Nicholas N Hoke
    • 1
  • Antonio Abbate
    • 1
  • Amit Varma
    • 1
  • Ramzi A Ockaili
    • 1
  • Stefano Toldo
    • 1
  • Fadi N Salloum
    • 1
  1. 1.Division of Cardiology, Department of Internal MedicineVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations